NEW
YORK, June 20, 2024 /PRNewswire/ -- The Gross
Law Firm issues the following notice to shareholders
of Altimmune, Inc. (NASDAQ: ALT).
Shareholders who purchased shares of ALT during the class period
listed are encouraged to contact the firm regarding possible lead
plaintiff appointment. Appointment as lead plaintiff is not
required to partake in any recovery.
CONTACT US HERE:
https://securitiesclasslaw.com/securities/altimmune-inc-loss-submission-form/?id=86302&from=4
CLASS PERIOD: December 1,
2023 to April 26, 2024
ALLEGATIONS: The complaint alleges that
during the class period, Defendants issued materially false and/or
misleading statements and/or failed to disclose that: (i) Altimmune
overstated the potential for its lead product candidate,
pemvidutide, to stand out from competing glucagon-like peptide-1
agonists based on the drug's efficacy and tolerability results
observed in the MOMENTUM Trial; (ii) accordingly, the MOMENTUM
Trial results were less significant to pemvidutide's clinical,
commercial, and competitive prospects than Defendants had led
investors to believe; (iii) as a result of all the foregoing,
defendants had overstated Altimmune's prospects for finding a
strategic partner to develop pemvidutide; and (iv) as a result, the
Company's public statements were materially false and misleading at
all relevant times.
DEADLINE: July 5, 2024
Shareholders should not delay in registering for this class action.
Register your information here:
https://securitiesclasslaw.com/securities/altimmune-inc-loss-submission-form/?id=86302&from=4
NEXT STEPS FOR SHAREHOLDERS: Once you register as a
shareholder who purchased shares of ALT during the timeframe listed
above, you will be enrolled in a portfolio monitoring software to
provide you with status updates throughout the lifecycle of the
case. The deadline to seek to be a lead plaintiff is July 5, 2024. There is no cost or obligation to
you to participate in this case.
WHY GROSS LAW FIRM? The Gross Law Firm is a nationally
recognized class action law firm, and our mission is to protect the
rights of all investors who have suffered as a result of deceit,
fraud, and illegal business practices. The Gross Law
Firm is committed to ensuring that companies adhere to responsible
business practices and engage in good corporate citizenship. The
firm seeks recovery on behalf of investors who incurred losses when
false and/or misleading statements or the omission of material
information by a company lead to artificial inflation of the
company's stock. Attorney advertising. Prior results do not
guarantee similar outcomes.
CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (646) 453-8903
View original content to download
multimedia:https://www.prnewswire.com/news-releases/altimmune-inc-securities-fraud-class-action-lawsuit-pending-contact-the-gross-law-firm-before-july-5-2024-to-discuss-your-rights--alt-302177393.html
SOURCE Gross Law Firm